TY - JOUR
T1 - Percutaneous closure of patent foramen ovale for the secondary prevention of decompression illness in sports divers
T2 - mind the gap
AU - Eede, Martin Vanden
AU - Van Berendoncks, An
AU - De Wolf, Daniel
AU - De Maeyer, Catherine
AU - Eede, Hervé Vanden
AU - Germonpré, Peter
N1 - Publisher Copyright:
Copyright © 2019 Undersea & Hyperbaric Medical Society, Inc.
PY - 2019
Y1 - 2019
N2 - Objective: To evaluate the efficiency of percutaneous patent foramen ovale (PFO) closure on the recurrence of decompression illness (DCI). Design: Retrospective, observational study with interview and questionnaire Setting: Tertiary referral center. Population: 59 scuba divers with a history of DCI who received a percutaneous PFO closure. Main outcome measurements: Questionnaire about health status, dive habits and recurrence of DCI after PFO closure. Results: A total of 59 divers with DCI were included. The most common manifestations of DCI were cutaneous or vestibular DCI. Procedural complications occurred in four patients but none with long-term consequences. Four patients had recurrence of DCI after closure during a 10-year follow-up. In three of these cases there was residual shunting, all of which were initially considered closed. The fourth patient had aggravating factors for his recurrent DCI. A quarter of the patients stated to have changed their diving habits. Four patients quit diving. Conclusion: Percutaneous PFO closure for secondary prevention of DCI is associated with few, but not negligible, complications. As a large portion of our cohort changed their diving habit after closure it is difficult to ascertain the efficiency of PFO closure for secondary prevention of DCI. However, the study shows that PFO closure does not fully protect against DCI, emphasizing that the relationship between PFO and DCI is but an association. As such it is imperative that divers be counseled to ensure they understand the risks as well as the benefits of percutaneous PFO closure in their specific case.
AB - Objective: To evaluate the efficiency of percutaneous patent foramen ovale (PFO) closure on the recurrence of decompression illness (DCI). Design: Retrospective, observational study with interview and questionnaire Setting: Tertiary referral center. Population: 59 scuba divers with a history of DCI who received a percutaneous PFO closure. Main outcome measurements: Questionnaire about health status, dive habits and recurrence of DCI after PFO closure. Results: A total of 59 divers with DCI were included. The most common manifestations of DCI were cutaneous or vestibular DCI. Procedural complications occurred in four patients but none with long-term consequences. Four patients had recurrence of DCI after closure during a 10-year follow-up. In three of these cases there was residual shunting, all of which were initially considered closed. The fourth patient had aggravating factors for his recurrent DCI. A quarter of the patients stated to have changed their diving habits. Four patients quit diving. Conclusion: Percutaneous PFO closure for secondary prevention of DCI is associated with few, but not negligible, complications. As a large portion of our cohort changed their diving habit after closure it is difficult to ascertain the efficiency of PFO closure for secondary prevention of DCI. However, the study shows that PFO closure does not fully protect against DCI, emphasizing that the relationship between PFO and DCI is but an association. As such it is imperative that divers be counseled to ensure they understand the risks as well as the benefits of percutaneous PFO closure in their specific case.
KW - DCI
KW - PFO, decompression illness
KW - patent foramen ovale
KW - percutaneous closure
UR - http://www.scopus.com/inward/record.url?scp=85074546943&partnerID=8YFLogxK
U2 - 10.22462/10.12.2019.6
DO - 10.22462/10.12.2019.6
M3 - Article
C2 - 31683360
AN - SCOPUS:85074546943
SN - 1066-2936
VL - 46
SP - 625
EP - 632
JO - Undersea and Hyperbaric Medicine
JF - Undersea and Hyperbaric Medicine
IS - 5
ER -